Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Get Alerts AMGN Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.4%
EPS Growth %: -1.3%
Join SI Premium – FREE
THOUSAND OAKS, Calif., Sept. 13, 2016 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:45 a.m. GMT on Friday, Sept. 16, 2016, in London. David W. Meline, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
About AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand OaksKristen Davis, 805-447-3008 (media)Kristen Neese, 805-313-8267 (media)Arvind Sood, 805-447-1060 (investors)
Logo - http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-global-healthcare-conference-300327260.html
SOURCE Amgen
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Reiterates Overweight Rating on Amgen (AMGN)
- SEABOURN ANNOUNCES WESTERN KIMBERLEY TRADITIONAL OWNERS, WUNAMBAL GAAMBERA, AS GODPARENTS OF SEABOURN PURSUIT
- Biomass Power Generation Market Surges to USD 92.29 Billion in 2023, Anticipated Growth to USD 117.01 Billion by 2031 with 3.01% CAGR
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!